Using two breast cancer cell lines (i.e. MCF-7 and MDA-MB-231), Tsai et al., (2007) demonstrated that DHTS significantly inhibits the proliferation of breast cancer cells by modulating the cell cycle genes i.e. cyclin D1, cyclin D3, cyclin E, and CDK4. The gene discussed is CCND1; the disease is breast carcinoma.